Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NeuroPace Inc Director's Dealing 2021

Apr 20, 2021

33194_dirs_2021-04-20_f91adec0-f2af-4083-a326-699f56728efc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20

Reporting Person: LACOB JOSEPH (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 192 Direct
Common Stock 16833 Indirect
Common Stock 868 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A' Preferred Stock $0.00 Common Stock (8594) Indirect
Series A' Preferred Stock $0.00 Common Stock (17189) Indirect
Series B' Preferred Stock $0.00 Common Stock (102747) Indirect
Series B' Preferred Stock $0.00 Common Stock (205497) Indirect
Stock Option (Right to Buy) $0.03 2022-11-12 Common Stock (192) Direct

Footnotes

F1: Shares are held by Lacob Ventures LLC.

F2: Shares are held by LCT18 Investments.

F3: Each share of Preferred Stock automatically converts on a 1-for-1 basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.

F4: 1/48th of the shares subject to the option vest in equal monthly installments commencing December 13, 2012.